Thomas P. Leist, MD, PhD, a neurologist and professor of Multiple Sclerosis at Jefferson University Hospitals, is the latest guest featured on MHE Talks: Improving Patient Access podcast. In this episode, Thomas spoke with Peter Wehrwein, senior editor of Managed Healthcare Executive, about accessing care amongst patients with MS through therapies, health insurance barriers, options of step therapy and more.
The decision by Roche comes shortly after AstraZeneca withdrew the bladder cancer indication for durvalumab (Imfinzi).
Healthcare has successfully pivoted and collaborated. But COVID-19 also has spotlighted flaws in how hospitals are financed and the weakness of the public health infrastructure.
Market research firm sees growth in sales for injectable therapies developed with an eye toward improving adherence. Sales in pre-exposure prophylaxis are also projected to increase.
Valued-based care helped some providers weather the pandemic. The seven-course "specialization" on Coursera will help providers, others understand how value-based care works.
The rapid implementation of telehealth viewed favorably by providers involved in HIV care yet there are conflicting results on how well it facilitates patient retention.
Will emerging variants make the leading vaccines less protective?
Hesitancy seems to be waning, Merck extends helping hand to J&J, US bishops say J&J is "morally acceptable," and Biden promises large enough supply for all adults by May
Nursing homes see an 82% drop - the lowest amount of new COVID-19 cases since CMS started tracking in May 2020.
Study in Colorado maps correlations between social risk factors and emergency department use, including the "superutilizers."
Aetna got out of the ACA marketplace business in 2018. Now CVS Health, which completed its acquisition of the insurance company in late 2018, is hopping back in and will brand the policies as a “CVS Health-Aetna” product for the first time.
Blue Cross and Blue Shield of Minnesota say tha
Taming U.S. healthcare spending is a huge, daunting task that has met with little success. But some Yale professors are proposing to take a bite-sized approach as a way to change that.
The Trump administration didn’t get very far with healthcare reform; the ACA was neither repealed nor replaced. But former CMS Administrator Seema Verma made a run at revamping Medicaid by using Section 1115 waivers to add working requirements. Now the Biden administration is taking steps to stop the requirements before they get started.
Briana Contreras, associate editor of MHE, spoke with Robin Fiorelli, senior director of bereavement and volunteers at VITAS Healthcare, for this week's episode of Tuning In to the C-Suite. Robin and Briana talked about the grief that has affected millions of Americans and millions more throughout the world due to losing loved ones to COVID-19. They also discussed the implications of grief, strategies for coping and efforts underway to help the healthcare industry and consumers train and prepare for a suspected wave of grief that’s to come.
The number of aging Americans 65 years and older is projected to nearly double over the next 40 years, reaching 80 million in 2040. As the U.S. population ages, so too does the prevalence of medically complex patients with conditions that require ongoing medical attention, limit activities of daily living or both.
Collaboration between health plans and providers leads to better quality, an improved experience and lower costs.
Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin.
Harvard drug policy experts say in an opinion piece in JAMA that a drug affordability commission might be one of several ways that the new administration deals with prescription drug prices.
Young and middle-aged adults ages 25- to 64-years old in the U.S. have been dying at higher rates since 2010, according to a new report from the National Academies of Sciences, Engineering, and Medicine.
Results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost, were recently released by AllianceRx Walgreens Prime.
The value-based model hasn't produced cost savings and is not likely "to make the cut" to become permanent, says Kavita Patel, a former top healthcare official in the Obama administration.
More than one out of every 10 seniors enrolled in a Medicare Advantage plan and living in a rural area switched to traditional Medicare in the last few years, prior to the pandemic. The switch was driven primarily due to low satisfaction with care access, according to a study recently published in Health Affairs from researchers at Drexel University’s Dornsife School of Public Health.
As the world remains to try and reach a normal with vaccines finding their way into people’s arms, the insurance industry is trying to do the same by this spring.
Injectables are driving the growth because they can be taken less frequently and adherence is a problem with oral medications.
Health organizations that had RPM solutions in place pre-pandemic have been more successful at scaling up than organizations that were starting from scratch during the pandemic.
Though value-based care is a critically important topic today, the question of—and obsession with—healthcare value goes back more than half a century.
Following the unanimous endorsement from an FDA panel, it will be shocking if the single-dose vaccine doesn't get an EUA.
Data sharing in healthcare has unlocked more potential to use information and analytics to work toward addressing disparities and achieving health equity in care.
